Title: Quinol derivatives as potential trypanocidal agents.
Journal: Bioorganic & medicinal chemistry 20120215
Title: Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism.
Journal: The Journal of biological chemistry 20110311
Title: Structure of Mycobacterium tuberculosis thioredoxin in complex with quinol inhibitor PMX464.
Journal: Protein science : a publication of the Protein Society 20110101
Title: Heteroaromatic 4-arylquinols are novel inducers of nuclear factor-erythroid 2-related factor 2 (Nrf2).
Journal: European journal of pharmacology 20100925
Title: Hydrolysis and photolysis of 4-Acetoxy-4-(benzothiazol-2-yl)-2,5-cyclohexadien-1-one, a model anti-tumor quinol ester.
Journal: The Journal of organic chemistry 20090619
Title: Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions.
Journal: Journal of medicinal chemistry 20070405
Title: Antitumor quinols: role of glutathione in modulating quinol-induced apoptosis and identification of putative cellular protein targets.
Journal: Biochemical and biophysical research communications 20060721
Title: Elucidation of thioredoxin as a molecular target for antitumor quinols.
Journal: Cancer research 20050501
Title: Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.
Journal: British journal of cancer 20050131
Title: Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Journal: Journal of medicinal chemistry 20050127
Title: 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines.
Journal: Journal of medicinal chemistry 20030213
